MasTec Interest Paid decreased by 2.7% to $44.18M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 1.9%, from $45.02M to $44.18M. Over 4 years (FY 2021 to FY 2025), Interest Paid shows an upward trend with a 30.0% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase in interest paid relative to debt levels may signal rising borrowing costs or higher leverage, while a decrease may indicate debt reduction or refinancing at lower rates.
The total cash outflow for interest payments on debt obligations, typically disclosed as a supplemental item in the cash...
Essential for comparing the cost of capital and debt burden across peers in the pharmaceutical industry.
interest_paid| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $6.71M | $20.73M | $12.68M | $23.18M | $11.33M | $34.82M | $37.16M | $59.44M | $52.53M | $75.38M | $50.29M | $61.82M | $42.80M | $46.35M | $44.37M | $45.02M | $42.81M | $43.22M | $45.41M | $44.18M |
| QoQ Change | — | +208.9% | -38.8% | +82.8% | -51.1% | +207.4% | +6.7% | +60.0% | -11.6% | +43.5% | -33.3% | +22.9% | -30.8% | +8.3% | -4.3% | +1.5% | -4.9% | +1.0% | +5.1% | -2.7% |
| YoY Change | — | — | — | — | +68.8% | +68.0% | +193.0% | +156.5% | +363.6% | +116.5% | +35.4% | +4.0% | -18.5% | -38.5% | -11.8% | -27.2% | +0.0% | -6.7% | +2.4% | -1.9% |